Dinah Sah

Dinah Sah is an accomplished scientist with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Co-Executive Director at Caribbean Science Foundation since February 2012, Dinah also holds positions as Chief Scientific Officer and member of the Scientific Advisory Board at Voyager Therapeutics, Inc. since March 2014. Additional roles include President and Director at CADSTI-NEW ENGLAND INC. from April 2014 onward. Prior experience includes influential positions at Alnylam Pharmaceuticals, Biogen Idec, and Signal Pharmaceuticals, showcasing a robust background in research leadership, particularly in neuroscience and oncology. Dinah holds a B.S. in Biology from the Massachusetts Institute of Technology and a PhD in Neurobiology from Harvard University.